R01CA09242308/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

MC-12, an annexin A1-based peptide, is effective in the treatment of experimental colitis.

Ouyang N, Zhu C, Zhou D, Nie T, Go MF, Richards RJ, Rigas B. Ouyang N, et al. PLoS One. 2012;7(7):e41585. doi: 10.1371/journal.pone.0041585. Epub 2012 Jul 23. PLoS One. 2012. PMID: 22844504 Free PMC article.

Topical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancer.

Cheng KW, Mattheolabakis G, Wong CC, Ouyang N, Huang L, Constantinides PP, Rigas B. Cheng KW, et al. Int J Oncol. 2012 Oct;41(4):1199-203. doi: 10.3892/ijo.2012.1577. Epub 2012 Jul 27. Int J Oncol. 2012. PMID: 22842609 Free PMC article.

Phospho-sulindac (OXT-328) inhibits the growth of human lung cancer xenografts in mice: enhanced efficacy and mitochondria targeting by its formulation in solid lipid nanoparticles.

Zhu R, Cheng KW, Mackenzie G, Huang L, Sun Y, Xie G, Vrankova K, Constantinides PP, Rigas B. Zhu R, et al. Pharm Res. 2012 Nov;29(11):3090-101. doi: 10.1007/s11095-012-0801-x. Epub 2012 Jun 22. Pharm Res. 2012. PMID: 22723123 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters